Last reviewed · How we verify
EpiCeram
At a glance
| Generic name | EpiCeram |
|---|---|
| Also known as | BRC-Cer |
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Seal, Stopping Eczema and Allergy Study (PHASE2)
- Wound Healing Endpoint and Recurrence (PHASE1, PHASE2)
- Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics (NA)
- Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease (NA)
- A Multiple-Dose Study of LY3493269 in Healthy Participants (PHASE1)
- EpiCeram for Skin Protection in Healthcare Workers (NA)
- The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants (PHASE3)
- Effect of Different Skin Creams on TEWL (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |